Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit J Arsenault

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Pharmacogenomics|September 21, 2016
Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatmentRoelof Aj Smit, Iris Postmus, Stella Trompet, et al.
American Journal of Lifestyle Medicine|April 28, 2025
Impact of Lifestyle Medicine Interventions on the Management of Systemic Hypertension in Primary Care: A Canadian Randomized Controlled TrialElisa Marin-Couture, Julie-Alexandra Moulin, Anne-Sophie Thibault, et al.
Physiological Reports|March 2, 2019
Acute and chronic effect of bariatric surgery on circulating autotaxin levelsRaphaëlle Bourgeois, Marie-Eve Piché, Audrey Auclair, et al.
Metabolites|May 28, 2022
Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver DiseaseÉmilie Gobeil, Ina Maltais-Payette, Nele Taba, et al.
Metabolites|August 6, 2021
Lipoprotein Proteomics and Aortic Valve Transcriptomics Identify Biological Pathways Linking Lipoprotein(a) Levels to Aortic StenosisRaphaëlle Bourgeois, Jérôme Bourgault, Audrey-Anne Despres, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2026
Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver diseaseÉmilie Gobeil, Jérôme Bourgault, Eloi Gagnon, et al.
CJC Open|May 24, 2021
A Comparative Analysis of the Lipoprotein(a) and Low-Density Lipoprotein Proteomic Profiles Combining Mass Spectrometry and Mendelian RandomizationRaphaëlle Bourgeois, Arnaud Girard, Nicolas Perrot, et al.
European Heart Journal Open|April 20, 2023
Impact of C-reactive protein levels on lipoprotein(a)-associated aortic stenosis incidence and progressionArnaud Girard, Emilie Gaillard, Rishi Puri, et al.
Heart (British Cardiac Society)|July 9, 2020
Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humansNicolas Perrot, Sébastien Thériault, Sidwell Rigade, et al.
Cell Reports. Medicine|November 29, 2021
Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver diseaseNooshin Ghodsian, Erik Abner, Connor A Emdin, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Pharmacogenomics|September 21, 2016
Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatmentRoelof Aj Smit, Iris Postmus, Stella Trompet, et al.
American Journal of Lifestyle Medicine|April 28, 2025
Impact of Lifestyle Medicine Interventions on the Management of Systemic Hypertension in Primary Care: A Canadian Randomized Controlled TrialElisa Marin-Couture, Julie-Alexandra Moulin, Anne-Sophie Thibault, et al.
Physiological Reports|March 2, 2019
Acute and chronic effect of bariatric surgery on circulating autotaxin levelsRaphaëlle Bourgeois, Marie-Eve Piché, Audrey Auclair, et al.
Metabolites|May 28, 2022
Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver DiseaseÉmilie Gobeil, Ina Maltais-Payette, Nele Taba, et al.
Metabolites|August 6, 2021
Lipoprotein Proteomics and Aortic Valve Transcriptomics Identify Biological Pathways Linking Lipoprotein(a) Levels to Aortic StenosisRaphaëlle Bourgeois, Jérôme Bourgault, Audrey-Anne Despres, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2026
Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver diseaseÉmilie Gobeil, Jérôme Bourgault, Eloi Gagnon, et al.
CJC Open|May 24, 2021
A Comparative Analysis of the Lipoprotein(a) and Low-Density Lipoprotein Proteomic Profiles Combining Mass Spectrometry and Mendelian RandomizationRaphaëlle Bourgeois, Arnaud Girard, Nicolas Perrot, et al.
European Heart Journal Open|April 20, 2023
Impact of C-reactive protein levels on lipoprotein(a)-associated aortic stenosis incidence and progressionArnaud Girard, Emilie Gaillard, Rishi Puri, et al.
Heart (British Cardiac Society)|July 9, 2020
Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humansNicolas Perrot, Sébastien Thériault, Sidwell Rigade, et al.
Cell Reports. Medicine|November 29, 2021
Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver diseaseNooshin Ghodsian, Erik Abner, Connor A Emdin, et al.
Pageof 16